King'S Fertility Limited

Business Review: King's Fertility is a fertility clinic in London that is defined by decades of experience, world-renowned research and the most innovative technology. We are the only fertility clinic in the UK which is the result of a partnership between a charity, the NHS and a leading international academic institution, King's College London. We are owned by the Fetal Medicine Foundation (FMF), a registered charity whose aim is to promote the health of pregnant women and their babies through research and training in fetal and fertility medicine. All of our profits go back into the FMF, which means that we are able to invest in the best people, the best technology, the best equipment, the best research and training. We are also part owned by King's College Hospital (KCH), one of the largest NHS Foundation Trusts in the country. This means that we are able to share in that multi-speciality expertise to get the best possible outcome for challenging cases. For example, advanced laparoscopic surgery for endometriosis, renal cases, oncology, haematology etc. Through our association with King's College Hospital, we are part of the King's College London (KCL) and many of our consultants hold academic posts at KCL. We conduct a number of research projects collaboratively with KCL as well as a number of projects on our own. It's been well documented that research active medical centres have better medical outcomes for patients than those that don't engage in research. Our research-rich environment ensures that we are continually at the forefront of science and knowledge. We also operate as a private fertility clinic which means we're not limited by the bureaucracy that often constrains organisations such as the NHS, universities or other large corporations. We're a dynamic, multidisciplinary team that's able to deliver a first class, individually tailored patient experience in an uplifting environment. Risk Management The Directors have conducted a review of the major risks to which the company is exposed. Where appropriate, systems or procedures have been established to mitigate the risks the company faces. Internal control risks are minimised by the implementation of procedures for authorisation of all transactions and projects. Procedures are in place to ensure compliance with health and safety of staff, volunteers, clients, patients and visitors. These procedures are periodically reviewed to ensure that they continue to meet the needs of the company. Principal Risks and Uncertainties The Directors are satisfied that for all major risks identified appropriate controls have been put in place and maintained to mitigate those risks adequately. It is recognised that systems can provide only reasonable, but not absolute assurance that major risks have been managed. The principal risks and uncertainties are assessed as: - Financial Risk - the principal concern is an adverse change in the economic or regulatory conditions, which reduced the affordability of fees and results in a reduction in fee income. The Company mitigates this risk by a regular review of its forecasts and level of reserves. - Reputational Risk - the principal risk is a current or historic failure leading to a loss of reputation. This risk is managed by a balanced approach of controls and training. There is regular training and the Parent company has the required talent to train team members. Objectives and Activities for the public benefit The principal activity of the company since its formation in 2017 and during the year under review was to raise money in order to achieve its principal objectives. The principal objectives are - to provide our fertility services to the various Hospitals in the UK and general public in the UK and general public. - to run a successful and profitable business. Most of our company's surplus income is donated to our parent company/charity, The Fetal Medicine Foundation, and used for the promotion and development of new methods for fetal diagnosis and therapy through research and encourage and facilitate the controlled clinical introduction of such methods through lectures, training and funding of doctors. Analysis of the Development and Performance of our Business: Our company provides a very wide range of fertility services that can be summarised in the following general categories: - female fertility: included are diagnosis, treatments, egg freezing, shared motherhood, various lab techniques. - male fertility: male fertility diagnosis and treatments - transgender fertility: female to male and male to female - specialist services: infertility counselling, genetic counselling, genetic testing, sperm donation, egg donation, surrogacy. The successful performance of our business is outline in our website https:\\kingsfertility.co.uk Financial Results of our Business: The financial results of our company for the year ended 31 March 2025 are set out in the statement of income and expenditure and retained earnings on page 10. Fixed Assets Details of movements in fixed assets are shown in note (10) to the accounts. Intangible Assets Details of movements in Intangible assets are shown in note (9) to the accounts